---
figid: PMC9673067__mmr-27-01-12889-g01
pmcid: PMC9673067
image_filename: mmr-27-01-12889-g01.jpg
figure_link: /pmc/articles/PMC9673067/figure/f2-mmr-27-01-12889/
number: Figure 2
figure_title: ''
caption: 'DEX reduces T helper 2 cytokine production and airway hyperresponsiveness.
  (A) Commercial ELISA kits were used to assess the concentration of IL-4, IL-5 and
  IL-13 in bronchoalveolar lavage fluid. (B) Airway resistance of mice in response
  to nebulized methacholine of different concentrations (0, 6, 12, 24 and 48 mg/ml).
  Quantitative data are presented as the mean Â± SD (n=3). **P<0.01, ***P<0.001 and
  ****P<0.0001 vs. control; #P<0.05 and ##P<0.01 vs. OVA. DEX, dexmedetomidine; OVA,
  ovalbumin; Rrs, respiratory resistance.'
article_title: Dexmedetomidine attenuates airway inflammation and oxidative stress
  in asthma via the Nrf2 signaling pathway.
citation: Shilin Xiao, et al. Mol Med Rep. 2023 Jan;27(1):2.
year: '2023'

doi: 10.3892/mmr.2022.12889
journal_title: Molecular Medicine Reports
journal_nlm_ta: Mol Med Rep
publisher_name: D.A. Spandidos

keywords:
- dexmedetomidine
- oxidative stress
- allergic asthma
- airway inflammation
- nuclear factor erythroid 2-related factor 2

---
